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ABSTRACT 
A human nasal cavity was reconstructed from CT 
scans to make a Computational Fluid Dynamics 
(CFD) model. With this model, fluid flow and inhala-
tion of aerosol analysis can be investigated. The sur-
face of the interior nasal cavity is lined with highly 
vascularised mucosa which provides a means for di-
rect drug delivery into the blood stream. Typical 
sprayed particles from a nasal spray device produce 
a particle size distribution with a mean diameter of 
50μm, which leads to early deposition due to inertial 
impaction. In this study low-density drug particles 
and submicron particles (including nanoparticles) 
are used to evaluate their deposition patterns. It was 
found that the low-density particles lightens the par-
ticle inertial properties however the particle inertia is 
more sensitive to the particle size rather than the 
density. Moreover the deposition pattern for nano- 
particles is spread out through the airway. Thus an 
opportunity may exist to develop low-density and 
nanoparticles to improve the efficiency of drug de-
livery to target deposition on the highly vascularised 
mucosal walls. 
 
Keywords: Nasal Airway; Ultrafine, Fibre; Morphology; 
CFD; Deposition 
1. INTRODUCTION 
Nasal drug delivery provides an alternative approach to 
traditional delivery methods such as oral drug routes that 
fail in the systemic delivery of compounds due to its 
dissociation by the digestive system. The nasal airway is 
dominated by the nasal turbinates that are lined with 
highly vascularised mucosa opening to the paranasal 
sinuses. Because of these characteristics it is hypothe-
sised that drug delivery to combat health problems such 
as lung diseases, cancers, diabetes, sinus infections etc. 
may be viable if the drug formulation can be deposited 
in the turbinate region [1].  
Despite these advantages, studies have found that tar-
geted drug delivery is inefficient [2,3]. The atomisation 
of the drug formulation produces a mean droplet size of 
50μm [4] which exhibits high inertia. This leads to a 
large proportion of particles impacting in the anterior 
regions of the nasal cavity. Most drug formulations have 
close to unit density as they are suspensions in aqueous 
solutions. Lighter porous drug particles have been de-
veloped for pulmonary delivery [5], where the drug par-
ticle sizes are in the low micron to sub-micron range and 
deposition is targeted at the pulmonary airways that ex-
hibit much smaller spaces such as the airway branches in 
the lungs. Another alternative is the use of engineered 
nanoparticles which exhibit a large surface area to size 
ratio leading to greater biologic activity. This increased 
biologic activity can be exploited for targeted drug and 
gene delivery, tissue engineering, cell tracking and bio-
separation [6,7]. One advantage for nasal drug delivery 
is its extremely small size which would allow the parti-
cles to deposit through diffusion rather than inertial im-
paction. Thus an opportunity exists for the development 
of new porous-based particles and/or nano-sized parti-
cles for nasal drug delivery.  
Computational Fluid Dynamics (CFD) simulations 
have evolved into a feasible alternative to complement 
experimental data. For example CFD simulations for 
airflow patterns [8,9,10] have complemented experi-
mental results [11] by confirming regions of vortices 
within the nasal vestibule, the olfactory region and pos-
terior to the nasal valve. Simulations for particle deposi-
tion however, are fewer in numbers. Spherical particle 
deposition under conditions related to pharmaceutical 
nasal spray applications has been studied [3]. Particles in 
the range of 10 µm to 50 µm subjected to a breathing 
flow rate of 20L/min found that a large proportion of 
particles deposited in the anterior third of the nasal cav-
ity which were attributed to the injected particles exist-
ing in a high inertial regime. On the other hand nano- 
sized particles in the nasal cavity under laminar condi-
tions were simulated [12] which found that diffusion was 
the dominant deposition mechanism for the smallest 
range of particles (1–30 nm).  
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Figure 1. Steps in the construction of the computational model. 
 
Figure 2. Different views of the computational model. Three coronary slices 
and the inlet show the internal mesh with a dense region near the walls. 
 
A human nasal cavity was reconstructed from CT 
scans and a computational model developed for particle 
flow analysis within the airway. This study presents the 
use of CFD techniques to investigate the airflow patterns 
and deposition of low density and nano-sized particles for 
drug delivery in a human nasal cavity. The nasal airway 
was chosen for investigation as it is one of the major en-
tries into the respiratory system which can be penetrated 
to reach the blood streams. With this in mind, it is antici-
pated that this research will assist in new designs of 
aerosols and particulates and also help to guide practical 
clinical tests for toxicological and therapeutic studies. 
2. METHOD 
The model reconstruction involved four main steps  
(Figure 1): 1) CT images acquisition; 2) image process-
ing and editing to improve the quality of the image 
volume; 3) segmentation; and 4) surface reconstruction. 
CT images of a 25 yr-old Asian male (75kg, 170cm) 
provided a 3D matrix of volume elements (voxels), in 
which different tissues and structures having different 
attenuation characteristics were distinguished from one 
another by differences in brightness or greyscale. 
2.1. Image Processing 
The scan was performed using a CTI Whole Body 
Scanner (General Electric). The single-matrix scanner 
was used in helical mode with 1-mm collimation, a 
40-cm field of view (FOV), 120 kV peak and 200 mA to 
produce contiguous images (slices) of 1-mm thickness 
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Left Cavity                                                  Right Cavity 
Figure 3. Path streamlines in the left and right cavities. 
 
with voxel size 0.25×0.25×1 mm. The original set of CT 
images is converted into a file format compatible with 
the package MegaWave2 (MW2), by means of C lan-
guage self-developed routines. The conversion program 
also performs an image enhancement, by rescaling the 
grey-level histogram to 1-200 and remapping the image 
volume to an 8-bit/pixel depth file. 
A 3D convolution with a Gaussian kernel was used to 
reduce the background noise present in the images. Be-
cause of its isotropic shape, the Gaussian filter has opti-
mal properties such as smoothing mask, removing 
small-scale texture and noise, which could alter the re-
gional segmentation, without distorting lower spatial 
frequencies. Filtering was applied in three dimensions in 
order to obtain a smoothed CT image volume also along 
the axial direction. Such a procedure attenuates the spa-
tial discontinuities among the slices introduced during 
acquisition, as an effect of the slice thickness. 
2.2. Segmentation & Surface Reconstruction 
A 2D segmentation is used to detect and extract, slice by 
slice, the walls of the airway. For the segmentation 
process, a region growing algorithm, based on the 
Mumford and Shah [13] method implemented WM2 is 
used. The regional segmentation has been included be-
cause it allows the tracking only of the domains of inter-
est, even in the presence of noise. A first regional seg-
mentation with a greater number of partitioning regions 
than necessary is performed on each single slice. This 
allows the algorithm to detect the walls even in severely 
disturbed images. A threshold binarisation process is 
then applied in order to remove sub-regions unrelated to 
the airway, which typically present a lower intensity 
value with respect to the signal. In this wok, the thresh-
old has been empirically chosen and represents 45% of 
the maximum grey-level value of the study. Generation 
of a surface or solid model from the 2D contour data 
began with the translation of the segmented, modified 
and smoothed contour points into a data series that was 
read into CAD package used in this study: CATIA. The 
contours were lofted to define surface splines which en-
closed the airway volume. 
 
Right cavity                        Left Cavity 
x = 2.6cm from the anterior tip of the nose 
Figure 4. Contour plot of axial velocity (x-velocity) com-
bined with cross flow path streamlines (y-z velocity) in the 
left and right cavities. 
 
 
Figure 5. Deposition efficiency vs inertial parameter com-
parisons for the simulation micron spherical particles. 
2.3. Adaptive Meshing 
The CATIA models were imported into a 3D modelling 
program called GAMBIT. An initial model with 82,000 
cells was created and used to solve the air flow field at a 
flow rate of 7.5 L/min. The original model was refined 
by cell adaptation techniques that included refining large 
volume cells, cells that displayed high velocity gradients 
and near wall refinements. This process was repeated 
twice, with each repeat producing a model with a higher 
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cell count than the previous model. Subsequently four 
models were produced, 82000, 586000, 950000 and 1.44 
million cells. A grid independence test found that the 
results for average velocity converged at 950,000 cells. 
Subsequently the 950,000 cell model was used and is 
shown in Figure 2. 
2.4. Numerical Method 
Due to the complex geometry of the anatomically real 
nasal cavity a commercial CFD code, FLUENT, was 
used to predict the continuum air phase flow through 
solutions of the conservation equations of mass and 
momentum. The steady continuity and momentum equa-
tions for the gas phase (air) in Cartesian tensor notation 
are: 
  0gg i
i
u
x
                   (1) 
g g
gg i i
j g
j i j j
pu u
u
x x x x
          
            (2) 
where giu  is the i-th component of the time averaged 
velocity vector and g  is the air density. These equa-
tions were discretised using the finite volume approach. 
The third order accurate QUICK scheme was used to 
approximate the momentum equation whilst the pres-
sure-velocity coupling was realized through the SIMPLE 
method. To be consistent with experimental data, a con-
stant flow rate of 7.5 L/min. was used to simulate light 
breathing. At this flow rate, the flow regime has been  
determined to be laminar [11,14]. A steady flow rather 
than a cyclic unsteady flow was used in this case to al-
low the results to emphasize the effects of particle mor-
phology on deposition sites independent from cyclic 
conditions. Moreover the effects of a periodic inhalation 
on the overall flow field are found to be negligible from 
the Womersley frequency variable which is used to de-
termine the importance of the fluctuating sinusoidal pat-
tern of the inhalation-exhalation breathing cycle. The 
Womersley frequency variable, 
 0.52 gW D                 (3) 
was calculated as 0.3 where D is the local cross-sectional 
distance between the two nasal walls and is about 0.5 cm 
in this nasal cavity, g is the kinematic viscosity of air 
and ω is the breathing frequency.  
2.5. Drug Particles 
For spherical particles the drag force is related to the 
drag coefficient which has been studied quite extensively. 
The general correlation for smooth spherical particles is 
given as [15]: 
 24 18Re 18 2.367 Re wD pC    p  for Re<20     (4)  
 
Table 1. Deposition efficiency based on Figure 5. 
Density dae Inertial Parameter (IP) 
Deposition % present simu-
lation 
100 15.8 41,667 67.4% 
200 22.4 83,333 95.3% 
1000 50.0 416,667 100% 
 
 
 
50μm 100 kg/m3 
 
 
50μm 1000 kg/m3 
Figure 6. Deposition pattern for low density particles where ρ = 100kg/m3 and 1000kg/m3.
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where  100.82 0.05 log Re pw    
For submicron particles the drag force per unit particle 
mass taking the form of Stokes' drag law [16] defined as, 
218 g pD i
p p c
iF u ud C

              (5) 
Cc is the Cunningham correction factor to Stokes' drag 
law. The Brownian force by Li and Ahmadi [17] can be 
re-arranged to highlight the diffusion coefficient as: 
2 221 B
B
d
k TF
m tD
                (6) 
where md is the mass of the particle, T is the absolute 
temperature of the fluid, ν is the kinematic viscosity, kB 
is the Boltzmann constant, and  is the diffusion co-
efficient. Eq.6 is inputted into the user-defined-function 
option in Fluent. Additional forces include Saffman's lift 
force [18] 
D
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d d d
 

             (7) 
and the thermophoretic force [19] 
1
T T
p
TF D
m T i
                   (8) 
Particle rebounding from the surfaces was ignored and 
particle deposition was determined when the distance 
between the particle centre and a surface was less than or 
equal to the particle radius.  
3. RESULTS AND DISCUSSION 
3.1. Airflow Patterns 
Path streamlines which act as massless particle tracers to 
track the flow path of the inhaled air, were released from 
the nostril inlet to provide visualisation of the flow field 
(Figure 3). The streamlines in the left nasal cavity at a 
flow rate of 7.5L/min show flow separation and reversed 
flow in the upper anterior part of the cavity (olfactory 
region). This low flow characteristic in the olfactory 
region is important as it is a defence mechanism that 
prevents particles whose trajectories are heavily de-
pendent on flow patterns from being deposited onto the 
sensitive olfactory nerve fibres, while vapours are al-
lowed to diffuse for olfaction. For both cavities, the air 
flow squeezes through the nasal valve region, before 
decelerating due to the expansion in the cross-sectional 
area. The nasal valve region is approximately 2cm from 
the nostril inlet. 
A cross-sectional area located just immediate of the 
anterior nasal valve at 2.6cm was chosen to reflect the 
rapid changes in the flow field. The cross-section shown  
 
Figure 7. Deposition efficiency of 1nm-150nm particles 
in a human nasal cavity at a steady inhalation rate of 
10L/min. 
 
in Figure 4 is from a frontal perspective (positive flow 
into the paper). The contours reflect the axial velocity 
(x-component of velocity) and are combined with 
streamlines of secondary flow (y-z component of veloc-
ity). The red contours are maximum values which repre-
sent the bulk flow regions. For the cross-section located 
at 2.6cm from the anterior tip of the nose, two vortices in 
the right cavity and one in the left are found. The bulk 
flow is found in the middle and upper regions of the both 
cavities. 
3.2. Deposition of Drug Particles 
A parameter used for normalizing impaction-dominant 
deposition studies is the inertial parameter, IP given by: 
2
aeIP Qd                  (9) 
where Q is the air flow rate, given in cm3/s and dae is the 
aerodynamic diameter given in µm. It is a convenient 
parameter that compares deposition against different 
flow rates and particle sizes at aerodynamic diameters. 
Monodispersed particles in the range of 1-30μm were 
released passively (with the airflow) into the nasal cavity 
at flow rates of 5, 7.5, 10 and 15L/min. The deposition 
of particles over a range of the inertial parameter is 
shown in Figure 5 and is compared with other experi-
mental results. 
Since the drug particles exhibit different densities, 
they can be compared in terms of their aerodynamic 
properties (inertia, and settling properties) through the 
equivalent aerodynamic diameter, dae defined as: 
/1000ae p pd d                (10) 
This means that a small diameter, very dense particle 
can have the same aerodynamic as a large diameter, but 
less dense particle if their dae are the same. 
Particles in the micron particle size range exist in the 
inertial regime where deposition by inertial impaction is  
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(a) Side view  
individual particle deposition 
 
(c) Side view – contours of normalised local regional 
deposition 
 
(b) Top view  
individual particle deposition 
 
(d) Top view – contours of normalised local regional 
deposition 
Ni / Nmax 
 
 
Figure 1. Regional deposition patterns of 1nm particles under a flow rate of 10L/min in a human nasal cavity. 
 
relevant. The idea of low-density porous drug particles 
will decrease the particle inertial properties, although 
this decrease is not as significant as changing the particle 
size. The inertial parameter incorporates both the geo-
metric equivalent spherical diameter along with the par-
ticle density to give the particle aerodynamic diameter 
(Eq.12). Thus a larger porous particle will have a 
smaller equivalent aerodynamic diameter than a particle 
of equal size but with a higher density. The effect of par-
ticle density on the deposition of a 50μm particle is 
shown below. 
The particle deposition patterns in the nasal cavity in 
Figure 6 shows particles with density of 100kg/m3 and 
1000kg/m3 for brevity as the deposition pattern for ρ = 
200kg/m3 becomes similar to that of ρ = 100kg/m3. For 
particles with densities of 100kg/m3 a portion of the par-
ticles deposit superiorly on the septum walls of both 
sides of the nasal cavity. This suggests that the fluid flow 
is close to the inner septum walls forcing the particles 
into this region. 
A second concentration of deposited particles oc-
curs at the back of the nasal cavity where the flow 
changes directions from horizontal to vertically 
downwards. The change in the flow direction causes 
the particles to impact in this region. For particles 
with density of 1000 kg/m3 deposition is found in the 
frontal area with only a small proportion of particles 
passing through the nasal valve region. These parti-
cles finally impact onto the superiorly on the septum 
wall of the left nasal cavity, however this pattern is 
not found in the right nasal cavity. 
Deposition of submicron particles (1 to 150nm) was 
simulated under a flow rate 10 L/min in order to make 
comparisons with experimental data reported by [20] 
which found deposition efficiencies for a variety of hu-
man subjects under a flow rate of 10 L/min. The solid 
line in Figure 7 corresponds to the CFD model predic-
tion. The deposition curve is high for very small 
nanoparticles and the particle diameter range in which 
the deposition drops from 72% to 18% is between 
1nm-10nm. From 10nm-150nm however, there is only a 
small change in the deposition curve from 18%-15%. 
This deposition curve profile is characteristic of the 
Brownian diffusion, where the particles are so small that 
the fluid may no longer be considered continuous. The 
trajectory of the nanoparticle is then caused by the colli-
sion of the air molecules and concentration gradients to 
produce the random motion. 
Local deposition patterns for a 1nm particle are shown 
in Figure 8. The deposition pattern of the 1nm particle is 
distributed evenly through the nasal cavity where the 
diffusion disperses the particles in all directions. The 
wall contours in Figure 8(c), (d) show regions of high 
concentrations which is determined by the number of 
particles that deposit onto a wall face divided the maxi-
mum number of particles that deposit on any one face. 
Few particles are able to reach the wider meatus region, 
and instead the particles remain close to the nasal septum 
wall (inner regions). High concentrations are found at the 
upper regions of the cavity with a higher distribution of 
deposition within that one area. 
In general the deposition pattern is spread out through 
the nasal cavity well. This has interesting applications 
for drug delivery where traditional nasal sprays are pro-
ducing micron sized droplets that are prone to inertial 
deposition. This deposition mechanism leads to high 
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inertial impaction (up to 100% for a mean atomised par- 
ticle droplet of 50μm) in the anterior region of the nasal 
cavity [2,3]. However for high drug efficacy, the deliv-
ery of the droplets needs to be deposited in the middle 
regions of the nasal cavity, where the highly vascularised 
walls exist. Smaller particles such as 1μm were found to 
be less affected by inertial properties, which allowed it 
to bypass the anterior region of the nasal cavity. How-
ever because of the particles ability to follow the stream-
lines more readily, the particles were less likely to de-
posit in any region of the nasal cavity and instead by-
passes it completely, leading to the undesired effects of 
lung deposition. Delivery of nanoparticles especially 
1nm-5nm particles therefore, can provide improved 
deposition in the middle regions whilst minimising deep 
lung deposition.  
4. CONCLUSIONS 
Simulations of air-particle flows in the nasal cavity 
found vortices primarily in the upper olfactory region 
and just posterior to the nasal valve where the geometry 
begins to expand. This suggests that high inertial parti-
cles are unlikely to reach the sensitive olfactory region. 
Multiple secondary flow regions were found in the lower 
middle regions within the nasal valve. Low density po-
rous drug particles lightens the particle inertial proper-
ties however the particle inertia was more sensitive to 
the particle diameter rather than its density. The deposi-
tion of nanoparticles in the nasal cavity was distributed 
evenly throughout the airway with a deposition that 
drops from 72% to 18% for 1nm to 10nm. Because of 
the evenly distributed deposition pattern for nanoparti-
cles there exists an opportunity to develop low-density 
and nanoparticles to improve the efficiency of drug de-
livery to target deposition on the highly vascularised 
mucosal walls.  
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